The impact of glucocorticoid use on the outcomes of rheumatoid arthritis in a multicenter ultrasound cohort study.
Fumiaki NonakaShoichi FukuiTohru MichitsujiYushiro EndoAyako NishinoToshimasa ShimizuMasataka UmedaRemi SumiyoshiTomohiro KogaNaoki IwamotoTomoki OriguchiYukitaka UekiNobutaka EirakuTakahisa SuzukiAkitomo OkadaNaoki MatsuokaHirokazu TakaokaHiroaki HamadaTomomi TsuruYojiro ArinobuToshihiko HidakaKeita FujikawaTamami YoshitamaYoshifumi TadaHideo OhtsuboJun IshizakiTomoyuki AsanoTakahiro MaedaAtsushi KawakamiShin-Ya KawashiriPublished in: International journal of rheumatic diseases (2024)
RA patients treated with glucocorticoids had a higher disease activity at baseline and a poorer response to treatments with b/tsDMARDs than those without glucocorticoids. The states of patients requiring glucocorticoids might be associated with the poor response to the b/tsDMARDs.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- ankylosing spondylitis
- rheumatoid arthritis patients
- end stage renal disease
- newly diagnosed
- ejection fraction
- juvenile idiopathic arthritis
- magnetic resonance imaging
- interstitial lung disease
- prognostic factors
- type diabetes
- adipose tissue
- cross sectional
- patient reported outcomes
- systemic sclerosis
- insulin resistance